When to screen for PAD? Prof. Dr.Tine De Backer Prof. Dr. Jean-Claude Wautrecht

Similar documents
Larry Diaz, MD, FSCAI Mehdi H. Shishehbor, DO, FSCAI

Joshua A. Beckman, MD. Brigham and Women s Hospital

Peripheral Arterial Disease Extremity

Imaging for Peripheral Vascular Disease

Garland Green, MD Interventional Cardiologist. Impact of PAD: Prevalence, Risk Factors, Testing, and Medical Management

USWR 23: Outcome Measure: Non Invasive Arterial Assessment of patients with lower extremity wounds or ulcers for determination of healing potential

The Changing Landscape of Managing Patients with PAD- Update on the Evidence and Practice of Care in Patients with Peripheral Artery Disease

Guidelines for Management of Peripheral Arterial Disease

National Clinical Conference 2018 Baltimore, MD

Cath Lab Essentials : Peripheral Vascular Disease in Patients with CAD

Peripheral Arterial Disease Management A Practical Guide for Internists. EFIM Vascular Working Group

Early Identification of PAD: Evidence to Refute USPSTF Position on Screening

Role of ABI in Detecting and Quantifying Peripheral Arterial Disease

Case Study: Chris Arden. Peripheral Arterial Disease

Peripheral Arterial Disease: Objectives. Disclosure. Definition: Peripheral Arterial Disease (PAD)

Introduction. Risk factors of PVD 5/8/2017

Due to Perimed s commitment to continuous improvement of our products, all specifications are subject to change without notice.

Goals of Screening Programs. What is Vascular Screening? Assumptions Regarding the Potential Benefits of Screening Programs PAD

Practical Point in Diabetic Foot Care 3-4 July 2017

TABLE OF CONTENTS. 2. LOWER EXTREMITY PERIPHERAL ARTERIAL DISEASE 2.1. Epidemiology Risk Factors

Introduction to Peripheral Arterial Disease. Stacey Clegg, MD Interventional Cardiology August

Perfusion Assessment in Chronic Wounds

The Peripheral Vascular System

SAVE LIMBS SAVE LIVES!

- Lecture - Recommandations ESC : messages importants P. MEYER (Saint Laurent du Var) - Controverse - Qui doit faire l'angioplastie périphérique?

Introduction to Peripheral Artery Disease. Dr. Tee Chee Hian

Peripheral Artery Disease Role of Exercise, Endovascular and Surgical Options

Practical Point in Holistic Diabetic Foot Care 3 March 2016

What s New in the Management of Peripheral Arterial Disease

Objective assessment of CLI patients Hemodynamic parameters

Peripheral Arterial Disease: Pathophysiology and Therapeutics

Peripheral Arterial Disease. Westley Smith MD Vascular Fellow

Peripheral Arterial Disease: Who has it and what to do about it?

Non-invasive examination

UC SF. Disclosures. Vascular Assessment of the Diabetic Foot. What are the best predictors of wound healing? None. Non-Invasive Vascular Studies

Surveillance of Peripheral Arterial Disease Cases Using Natural Language Processing of Clinical Notes

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

ASSESSING THE VASCULAR STATUS OF THE FEET FOR PATIENTS WITH DIABETES

STATINS FOR PAD Long - term prognosis

Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes

Detection of peripheral vascular disease in patients with type-2 DM using Ankle Brachial Index (ABI)

OUTPATIENT DEPARTMENT

Is there an association between atherosclerosis and chronic venous disease?

VASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS

Peripheral Arterial Disease: Screening, Evaluation and Management. Mitchel Sklar, MD, FACC, FSCAI. Cardiovascular Associates of R.I.

Radiologic Evaluation of Peripheral Arterial Disease

John E. Campbell, MD. Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division

Making the difference with Live Image Guidance

ANKLE BRACHIAL PRESSURE INDEX: AS A PREDICTOR OF PERIPHERAL ARTERIAL DISEASE IN DIABETIC & NON DIABETIC SUBJECTS

Disclosures. Critical Limb Ischemia. Vascular Testing in the CLI Patient. Vascular Testing in Critical Limb Ischemia UCSF Vascular Symposium

The Ankle- Brachial Pressure Index AS A Predictor of Coronary. Artery Disease Severity

Arterial Studies And The Diabetic Foot Patient

Current Vascular and Endovascular Management in Diabetic Vasculopathy

M. Arivumani * Original Research Article. Abstract

Treatment Strategies For Patients with Peripheral Artery Disease

Objectives. Abdominal Aortic Aneuryms 11/16/2017. The Vascular Patient: Diagnosis and Conservative Treatment

Peripheral Arterial Disease

PERIPHERAL ARTERIAL DISEASE (PAD); Frequency in diabetics.

Steven Hadesman, MD Chief Medical Officer, MeridianRx Internal Medicine Physician, St. John Hospital

Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease

Peripheral Vascular Examination. Dr. Gary Mumaugh Western Physical Assessment

How to manage leg ulcers in the elderly

7 th Munich Vascular Conference

The aching, cramping pain of

Arthroplasty after previous surgery: previous vascular problems

Clinical Approach to CLI and Related Diagnostics: What You Need to Know

3-year results of the OLIVE registry:

Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study

JOURNAL OF VASCULAR SURGERY Volume 32, Number 6 McDermott et al 1165 METHODS

Peripheral artery disease (PAD) is now the preferred term. Peripheral Artery Disease Compendium. Epidemiology of Peripheral Artery Disease

Predictors of an abnormal postexercise ankle brachial index: Importance of the lowest ankle pressure in calculating the resting ankle brachial index

Peripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment

ORIGINAL INVESTIGATION

Appendix D: Leg Ulcer Assessment Form

International Journal of Pharma and Bio Sciences

Ankle brachial index measured by palpation for the diagnosis of peripheral arterial disease

Non- invasive vascular testing. Pros and Cons of ABIs and Alternative Physiologic Assessments

Ankle brachial index performance among internal medicine residents

Limitation of the resting ankle brachial index in symptomatic patients with peripheral arterial disease

ABSTRACT INTRODUCTION. Use of Ankle-Brachial Index as a Predictor of Severity of Atherosclerosis

Will it heal? How to assess the probability of wound healing

Financial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017

Utility of Exercise-Induced Zero TBI Sign in Patients on Maintenance Hemodialysis

Is the Ankle-Brachial Index a Useful Screening Test for Subclinical Atherosclerosis in Asymptomatic, Middle-Aged Adults?

A new era in the treatment of peripheral artery disease (PAD)?

Medical Management of Vascular Disease KEITH E SWANSON MD ND ACADEMY OF FAMILY PHYSICIANS FAMILY MEDICINE UPDATE JANUARY 2017

Revascularisation for Claudication: When is it indicated, when not? Markus Haumer Landesklinikum Baden-Mödling Austria

Screening for peripheral vascular disease in patients with type 2 diabetes in Malta in a primary care setting

Cardiovascular Update for Primary Care Providers. Peripheral Vascular Disease October 4 th 2014 Roberto A. Corpus Jr., MD

Intercepting PAD. Playbook for Cardiovascular Care 2018 February 24, Jonathan D Woody, MD, FACS. University Surgical Vascular

LIBERTY 360 Study. 15-Jun-2018 Data 1. Olinic Dm, et al. Int Angiol. 2018;37:

Screening for Peripheral Artery Disease Using the Ankle-Brachial Index: An Updated Systematic Review for the U.S. Preventive Services Task Force

EVALUATION OF THE VASCULAR STATUS OF DIABETIC WOUNDS Travis Littman, MD NorthWest Surgical Specialists

The Struggle to Manage Stroke, Aneurysm and PAD

Overview. Arterial Disease: Carotid, Aortic and Peripheral Intensive Review in Internal Medicine 2012

Ankle Brachial Index as a Marker of Atherosclerosis in Chinese Patients with High Cardiovascular Risk

Progression of asymptomatic peripheral artery disease over 1 year

Limb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017

CVD Prevention, Who to Consider

Clinical Examination of VASCULAR PATIENTS. Stephanie Hirst & Alexander Sunde

Transcription:

When to screen for PAD? Prof. Dr.Tine De Backer Prof. Dr. Jean-Claude Wautrecht

How do we define asymptomatic PAD? A. ABI < 1 B. ABI < 0.9 C. ABI < 0.8 D. ABI > 1

How do we define asymptomatic PAD? A. ABI < 1 B. ABI < 0.9 C. ABI < 0.8 D. ABI > 1

Which % of the common population has A. < 1% asymptomatic PAD? B. 10%-20% C. >20% D. 5-10%

Which % of the common population has A. < 1% asymptomatic PAD? B. 10%-20% C. >20% D. 5-10%

Prevalence 3-10% total population has asymptomatic peripheral arterial disease (ABI<0.9) 1/4 tot 1/3 is symptomatic Increases with age Prognosis is independent of complaints (cardiovascular!)

The PARTNERS Registry (Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival) Hirsch AT et al, JAMA 2001;286: 1317-1324

Patients With PAD (%) Prevalence of PAD Increases With Age Rotterdam Study (ABI <0.9) 1 San Diego Study (PAD by noninvasive tests) 2 60 50 40 30 20 10 0 55-59 60-64 65-69 70-74 75-79 80-84 85-89 Age (years) ABI=ankle-brachial index 1. Meijer WT, et al. Arterioscler Thromb Vasc Biol. 1998;18:185-192. 2. Criqui MH, et al. Circulation. 1985;71:510-515.

Prevalence (%) Gender Differences in the Prevalence of PAD 18 16 14 12 10 8 6 4 2 Women Men 6880 Consecutive Patients (61% Female) in 344 Primary Care Offices 0 <70 70 74 75 79 80 84 >85 Age (years) Adapted from Diehm C. Atherosclerosis. 2004;172:95-105 with permission from Elsevier.

Prognosis in PAD determined by A. cardiovascular events B. limb amputation C. cancer D. lung disease

Natural History of PAD Age > 50 years Limb Morbidity Cardiovascular Morbidity / Mortality Stable Claudication 70-80% Worsening Claudication 10-20% Critical Limb Ischemia Nonfatal CV Events 20% Mortality 15-30% 1-2% CV Causes 75% Non CV Causes 25%

Relative Risk (95% CI) Relative Risk of Death in Patients with PAD 10 8 6 5.9 (3.0 6.6) 6.6 (2.9 14.9) 4 3.1 (1.9 4.9) 2 0 All Causes CVD CHD Cause of Death CI=confidence interval; CHD=coronary heart disease; CVD=cardiovascular disease. Criqui MH, et al. N Engl J Med. 1992;326:381-386.

Patients (%) 10-Year Natural History in Patients with Intermittent Claudication 100 80 60 40 20 Survival MI Intervention Amputation 0 0 1 2 3 4 5 6 7 8 9 10 Time (years) Ouriel K. Lancet. 2001;358;1257-1264.

Defining a Population At Risk for Lower Extremity PAD Age less than 50 years with diabetes, and one additional risk factor (e.g., smoking, dyslipidemia, hypertension, or hyperhomocysteinemia) Age 50 to 69 years and history of smoking or diabetes Age 70 years and older Leg symptoms with exertion (claudication) or ischemic rest pain Abnormal lower extremity pulse examination Known atherosclerotic coronary, carotid, or renal artery disease Positive Edinburgh questionnaire

Most important risk factor for PAD A. Cholesterol B. Diabetes mellitus C. Smoking D. Hypertension

Risk factors >> Smoking Diabetes Arterial Hypertension Hypercholesterolemia Renal Insufficiency Hyperhomocysteinemia CRP

Fontaine Classification I : no complaints II: pain with exercise = claudicatio intermittens IIa: > 200 m/250 m IIb: < 200 m/250 m III: pain at rest IV: trophic lesions

Rutherford Classification Degree Category Clinical 0 0 Asymptomatic I 1 Mild claudication I 2 Moderate claudication I 3 Severe claudication II 4 Ischemic rest pain II 5 Minor tissue loss, non-healing ulcus III 6 Major tissue loss > metatarsal level, functional foot loss Rutherford RB, J Vasc Surg 1997; 26: 517-538

62 year old smoker, pain in legs for 5 months What will you ask?

History When pain?: after how many meters walking, when walking in a hurry or uphill? Rest pain? Left leg right leg - bilateral? Where?: buttocks, upper legs, calfs How does the pain disappear? DD: orthopedic, back pain, neurogenic

Buttock claudication Thigh claudication Leg claudication Sole claudication

Claudication pain improves with A. Elevation of the leg B. Bending forward C. Standing still D. Laying down

Edinburgh Vragenlijst voor opsporen Claudicatio Intermittens Courtesy of prof. d. G Fowkes

Vascular review of symptoms 1.Exertional impairment 2.Wound healing 3. Leg or feet pain 4. Abdominal pain 5. Family history 6. Coronary artery disease 7. Cerebrovascular disease

Clinical examination Palpation peripheral pulses( carotides/ femorales/popliteae/dorsales pedis/tibiales posteriores) Auscultation (carotides, AA, iliacae, femorales) Color Cold = aspecific Trophic anomalies Delayed capillary refill

Vascular examination : how? Inspection (Percussion) BP 2 arms HR Rhythm Palpation Auscultation

D G Temporales + + Carotides + + Sous-clavières + + Humérales + + Radiales + + Cubitales + + Aorte + Iliaques (+) (+) Fémorales + + Fémorales sup. (+) (+) Poplitées + + Pédieuses + + Tibiales post. + + Péronières (+) (+) TRV - - symétriques? souffles? souffles? symétriques? souffle? diam.? sensible? souffles? souffles? symétriques? souffles? souffles? calibre? pressions perfusion pressions perfusion

B C D A A Dorsalis pedis B Tibialis anterior C Tibialis posterior D Peronealis

0 absent 1 diminished 2 normal 3 bounding Pulse intensity

Technical investigations Doppler Ultrasonography Strandness test Stepladdertest MR angio CT angio IA DSA

Doppler Ankle Brachial Index Belgische Cardiologische Liga Prof. dr. D. Clement

Doppler ABI meting

ABI is A. SBP arms/sbp legs B. DBP arms/dbp legs C. SBP legs/sbp arms D. DBP legs/dbp arms

Ankle-Brachial Index (ABI) ABI = Ankle systolic pressure Brachial systolic pressure Measure ankle and brachial systolic pressures with Doppler Use highest arm and each ankle pressures 1. TASC Working Group. Int Angiol 2000; 19 (suppl): 5-34. 2. Vascular Disease Foundation, 2003. Available at:http://www.vdf.org/abi.htm.

Doppler Measurement of pressure and registration of curve Ankle-Brachial index (ABI) Normal: Pressure Legs > Pressure Arms: ABI > 1 > 0.9 : still normal 0.8-0.9: mildly diminished 0.5-0.8: moderately diminished <0.5: strongly diminished Sensitivity of the test after exercise (walking test or tiptoeing) = Exercise ABI Abnormal ABI is independent predictor of cardiovascular mortality (RR~4) and cerebrovascular diseases (RR~2)

Treadmill test J. Strapart, Q Devreese, J.C. Wautrecht CFPV Paris, 15-17 Mars 2017

Orthopedics 2008 - Volume 31 Issue 8

Cave: Doppler: ABI Resting value can be false negative Normal to increased ABI if calcified vessels Non compressible vessels in diabetes False normal ABI with iliac stenosis: repeat immediately after walking/ knee bending ABI >1,40 (calcifications) (>1.30) TBI: Toe Brachial Index (< 0.70: PAD)

ABI A high level of specificity (83.3-99.0%) and accuracy (72.1-89.2%) was reported for an ABI 0.90 in detecting 50% stenosis, but there were different levels of sensitivity. Sensitivity was low, especially in elderly individuals and patients with diabetes. The test of ABI 0.90 can be a simple and useful tool to identify PAD with serious stenosis, and may be substituted for other non-invasive tests in clinical practice Sensitivity ~79% Specificity ~96% Ultrasound Med Biol 1996; Vasc Med. 2010 Oct;15(5):361-9

Usefulness ABI Confirms clinical suspicion of PAD Diagnosis in asymptomatic patients DD other causes of leg pain Prognostic information: < 0.9: RR cardiovascular mortality ~3-6 The lower ABI, the worse prognosis Strong correlation with coronary and cerebrovascular disease Risk stratification when increased risk profile

Total Mortality (%) Association Between ABI and All-Cause Mortality* 80 70 60 Risk increases at ABI values below 1.0 and above 1.3 N=5748 50 40 30 20 10 0 <0.61 0.61-0.70 0.71-0.80 0.81-0.90 0.91-1.00 1.01-1.10 1.11-1.20 1.21-1.30 1.31-1.40 >1.40 (n=156) (n=141) (n=186) (n=310) (n=709) (n=1750) (n=1578) (n=696) (n=156) (n=66) Baseline ABI Age range=mid- to late-50s; ABI=ankle-brachial index; *Median duration of follow-up was 11.1 (0.1 12) years. Adapted from O Hare AM et al. Circulation. 2006;113:388-393.

Percent (%) There is a strong correlation between the decrease of ABI and the increased risk of cardiovascular death 70 60 50 40 30 20 10 0 All-cause mortality CVD mortality Baseline ABI* *Mean participant follow-up 8.3 years Resnick HE et al. Circulation 2004; 109: 733-739.

Ankle Brachial Index (ABI) is an independent predictor of all-cause and coronary mortality in healthy middle-aged working Belgian men after eighteen year follow-up Coronary mortality JC Wautrecht et al. Europrevent 2006

CHD Event Outcomes per Year (%) Cardiovascular Risk Increases With Decreases in Ankle-Brachial Index Framingham High Risk = 20% at 10 years Every patient with PAD is at very high risk 4 3 2 5-year risk: 10% 2% 5-year risk: 19% 3.8% 1 0 1.4% >1.1 1.1 1.01 1.0 0.91 0.9 0.71 <0.7 ABI PAD *Fatal or nonfatal MI. ABI=ankle-brachial index; CHD=chronic heart failure Leng GC, et al. Brit Med J. 1996;313:1440-44.

Who to screen with ABI? All patients with exercise bound complaints in the legs Patients > 50 j with several risk factors Each pt > 70j All pts with CV risk 10-20% (Framingham) If +: behandel als secundaire preventie

People to screen with ABI < 50 j with diabetes mellitus, and one additional risk factor 50-69 j and diabetes mellitus or smoking > 50 j and several risk factors Cardiovascular risk 10-20% (Framingham) > 70 j Complaints/Symptoms in the legs at exercise Abnormal pulsations at clinical exam of the legs Known atherosclerotic coronary, carotid or renal disease Positieve Edinburgh questionnaire TvG 2017 in press; De Backer T, Vermassen F.

Thank You for your attention